BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 9950213)

  • 21. Single-molecule force spectroscopy study of interaction between transforming growth factor beta1 and its receptor in living cells.
    Yu J; Wang Q; Shi X; Ma X; Yang H; Chen YG; Fang X
    J Phys Chem B; 2007 Dec; 111(48):13619-25. PubMed ID: 17997544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
    Zhao Y; Shah DU
    Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
    Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
    Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
    Karlsson G; Liu Y; Larsson J; Goumans MJ; Lee JS; Thorgeirsson SS; Ringnér M; Karlsson S
    Physiol Genomics; 2005 May; 21(3):396-403. PubMed ID: 15769904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
    Nishikawa Y; Wang M; Carr BI
    J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S; Dong Z
    Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monomeric type I and type III transforming growth factor-β receptors and their dimerization revealed by single-molecule imaging.
    Zhang W; Yuan J; Yang Y; Xu L; Wang Q; Zuo W; Fang X; Chen YG
    Cell Res; 2010 Nov; 20(11):1216-23. PubMed ID: 20625381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
    Budasz-Rwiderska M; Jank M; Motyl T
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.
    Zeinoun Z; Teugels E; De Bleser PJ; Neyns B; Geerts A; De Greve J
    Anticancer Res; 1999; 19(1A):413-20. PubMed ID: 10226576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lateral diffusion of TGF-beta type I receptor studied by single-molecule imaging.
    Ma X; Wang Q; Jiang Y; Xiao Z; Fang X; Chen YG
    Biochem Biophys Res Commun; 2007 Apr; 356(1):67-71. PubMed ID: 17346672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
    J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
    Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
    Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.